Manuel Anderegg
@andereggman.bsky.social
kidney doc. enthusiastic for tea, genetics of kidney (stone) disease and (sometimes) kidney physiology
Reposted by Manuel Anderegg
🔥Inspiring keynote at the 1st Joint Mayo Charité Symposium by @asnkidney.bsky.social past president @susanquaggin.bsky.social on the golden era of #kidney health.
🫘🧪
#NephSky #MedSky @nephrointberlin.bsky.social
🫘🧪
#NephSky #MedSky @nephrointberlin.bsky.social
March 20, 2025 at 6:35 PM
🔥Inspiring keynote at the 1st Joint Mayo Charité Symposium by @asnkidney.bsky.social past president @susanquaggin.bsky.social on the golden era of #kidney health.
🫘🧪
#NephSky #MedSky @nephrointberlin.bsky.social
🫘🧪
#NephSky #MedSky @nephrointberlin.bsky.social
Was a great collaborative work with exciting outcome for patients with kidney stones!
Thanks goes to all patients, study nurses, colleagues, funders and last but not least of course the mastermind of it all @danfuster.bsky.social
Thanks goes to all patients, study nurses, colleagues, funders and last but not least of course the mastermind of it all @danfuster.bsky.social
Excited to share the results of our SWEESTONE trial 🔥🔥🔥@NatureMedicine
Wonderful collaboration with colleagues @unibern @inselgruppe and DCR Bern.
www.nature.com/articles/s41...
Empagliflozin substantially reduced urinary supersaturations in non-diabetic patients with kidney stones.
Wonderful collaboration with colleagues @unibern @inselgruppe and DCR Bern.
www.nature.com/articles/s41...
Empagliflozin substantially reduced urinary supersaturations in non-diabetic patients with kidney stones.
Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trial - Nature Medicine
As part of the SWEETSTONE trial, the authors report the ability of the sodium-glucose cotransporter 2 inhibitor empagliflozin to reduce the likelihood of kidney stone formation in individuals without ...
www.nature.com
January 2, 2025 at 1:29 PM
Was a great collaborative work with exciting outcome for patients with kidney stones!
Thanks goes to all patients, study nurses, colleagues, funders and last but not least of course the mastermind of it all @danfuster.bsky.social
Thanks goes to all patients, study nurses, colleagues, funders and last but not least of course the mastermind of it all @danfuster.bsky.social
Reposted by Manuel Anderegg
Optimist: The cup is half full
Pessimist: the cup is half empty
Internist: Both are in the differential, but I have ordered more imaging to ensure this is not actually a bowl. Will consider pottery consult.
Pessimist: the cup is half empty
Internist: Both are in the differential, but I have ordered more imaging to ensure this is not actually a bowl. Will consider pottery consult.
Optimist: The cup is half full
Pessimist: the cup is half empty
The nephrologist: It's only half a cup? We can dialyze that off, no problem.
Pessimist: the cup is half empty
The nephrologist: It's only half a cup? We can dialyze that off, no problem.
Optimist: The cup is half full
Pessimist: The cup is half empty
@traumasoapboxes.bsky.social: The cup is completely empty and needs blood, not saline
Pessimist: The cup is half empty
@traumasoapboxes.bsky.social: The cup is completely empty and needs blood, not saline
November 23, 2024 at 4:05 PM
Optimist: The cup is half full
Pessimist: the cup is half empty
Internist: Both are in the differential, but I have ordered more imaging to ensure this is not actually a bowl. Will consider pottery consult.
Pessimist: the cup is half empty
Internist: Both are in the differential, but I have ordered more imaging to ensure this is not actually a bowl. Will consider pottery consult.